Patent US4849340A successfully refreshed from Google Patents.
US4849340A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Reaction system element and method for performing prothrombin time assay
Assignee: Cardiovascular Diagnostics Inc
•
Filing: 1987-04-03
•
Granted: 1989-07-18
•
Expires: 2007-04-03
Abstract
Abstract An element and method for easily performing liquid assays are disclosed. The element uses capillary action to draw a predetermined volume of a liquid sample into a reaction chamber charged with reagent, where reaction between the liquid sample and the reagent is monitored.
Inventors
- 👤 Bruce Oberhardt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:16
CPC Classifications
B; B01; B01L; B01L3/00; B01L3/50; B01L3/502; B01L3/5023; B01F; B01F31/00; B01F31/30; B01F31/31; B01F33/00; B01F33/30; B01F35/00; B01F35/71; B01F35/717; B01F35/7172; B01L3/5027; B01L3/502715; B01L3/50273; G; G01; G01N; G01N33/00; G01N33/48; G01N33/483; G01N33/487; G01N33/49; G01N33/4905; G01N33/50; G01N33/52; G01N33/525; B01F21/00; B01F2101/00; B01F2101/23; B01F23/00; B01F23/40; B01F23/50; B01F23/56; B01L2300/00; B01L2300/06; B01L2300/0627; B01L2300/0654; B01L2300/069; B01L2300/08; B01L2300/0809; B01L2300/0825; B01L2300/0861; B01L2300/0864; B01L2300/087; B01L2300/0887; B01L2300/18; B01L2300/1805; B01L2300/1827; B01L2300/1861; B01L2400/00; B01L2400/04; B01L2400/0403; B01L2400/0406; B01L2400/06; B01L2400/0633; B01L2400/0655; B01L2400/0694; B01L3/502738; G01N21/00; G01N21/01; G01N21/03; G01N2021/0346; G01N35/00; G01N2035/00346; G01N2035/00435; G01N21/17; G01N21/47; G01N21/49; G01N21/51; G01N21/62; G01N21/63; G01N21/64; G01N21/645; G01N21/648; G01N21/75; G01N21/77; G01N21/78; G01N2201/00; G01N2201/06; G01N2201/066; G01N2201/0668; G01N35/0098; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/81; Y10S435/969; Y10S435/97; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/81
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
189 words
An analytical system for performing a prothrombin time assay comprising: (i) a reaction slide bearing (1) a sample well for receiving a liquid sample and (2) a reaction chamber containing a dry reagent matrix in which is embedded a plurality of magnetic particles distributed homogeneously therethrough, wherein said reagent is one member selected from the group consisting of prothrombin time assay reagents; (ii) said sample well and said reaction chamber being in fluid connection through a transport zone of geometry such that a volume of liquid sample placed in said reaction chamber is transported from said sample well to said reaction chamber simultaneously, (iii) means for optically monitoring said reaction chamber, (iv) means for subjecting said reaction chamber to an oscillating magnetic field, (v) whereby, when said sample is introduced into said reaction chamber, said dry reagent matrix is solubilized and said magnetic particles are thereby freed to move in an oscillating pattern induced by said osicllating magnetic field, thus providing a start and a stop time for said prothrombin time assay, corresponding to a change in the degree of said magnetic particle movement relative to said magnetic field.
Claim 2
Dependent Claim
189 words
An analytical system for performing a prothrombin time assay comprising: (i) a reaction slide bearing (1) a sample well for receiving a liquid sample and (2) a reaction chamber containing a dry reagent matrix in which is embedded a plurality of magnetic particles distributed homogeneously therethrough, wherein said reagent is one member selected from the group consisting of prothrombin time assay reagents; (ii) said sample well and said reaction chamber being in fluid connection through a transport zone of geometry such that a volume of liquid sample placed in said reaction chamber is transported from said sample well to said reaction chamber simultaneously, (iii) means for optically monitoring said reaction chamber, (iv) means for subjecting said reaction chamber to an oscillating magnetic field, (v) whereby, when said sample is introduced into said reaction chamber, said dry reagent matrix is solubilized and said magnetic particles are thereby freed to move in an oscillating pattern induced by said osicllating magnetic field, thus providing a start and a stop time for said prothrombin time assay, corresponding to a change in the degree of said magnetic particle movement relative to said magnetic field.
Claim 3
Dependent Claim
12 words
The analytical system of claim 1, wherein said magnetic particles are magnetite.
Claim 4
Dependent Claim
20 words
The analytical system of claim 1, further comprising a means for subjecting said reaction chamber to a permanent magnetic field.
Claim 5
Dependent Claim
22 words
The analytical system of claim 1, wherein said means for subjecting said reaction chamber to an osicllating magnetic field is an electromagnet.
Claim 6
Dependent Claim
23 words
The analytical system of claim 3, wherein said means for subjecting said reaction chamber to a permanent magnetic field is a permanent magnet.
Claim 7
Dependent Claim
33 words
The analytical system of claim 1, wherein said means for monitoring said reaction chamber comprises means for impinging light onto said reaction chamber and means for detecting light reflected from said reaction chamber.
Claim 8
Dependent Claim
39 words
The analytical system of claim 1, wherein said dry reagent matrix in which is embedded a plurality of magnetic particles is obtained by adding to said reaction chamber a slurry of reagent and magnetic particles and freeze drying same.
Claim 9
Dependent Claim
25 words
The analytical system of claim 7, wherein said magnetic aparticles are present in said slurry in an amount of 5 to 50 milligrams per milliliter.
Claim 10
Dependent Claim
17 words
The analytical system of claim 1, wherein said reagent comprises a combination of thromplastin and calcium chloride.
Claim 11
Independent Claim
196 words
A method for performing a prothrombin time assay, comprising: (i) subjecting to an oscillating magnetic field a reaction slide bearing (1) a sample well for receiving a liquid sample and (2) a reaction chamber containing a dry reagent matrix in which is embedded a plurality of magnetic particles distributed homogeneously therethrough, wherein said reagent is one member selected from the group consisting of prothrombin time assay reagents; said sample well and reaction chamber being in fluid connection through a transport zone of geometry such that a volume of liquid analyte sample placed in said sample well and corresponding to the volume of said reaction chamber is transported from said sample well to said reaction chamber simultaneously; (ii) adding a whole blood or plasma sample to said sample well whereby said sample is introduced simultaneously to said reaction chamber, said reagent is solubilized and said particles are freed to move in an oscillating pattern induced by said oscillating magnetic field; and (iii) optically monitoring said reaction chamber to measure a start time and a stop time for said prothrombin time assay, corresponding to a change in the degree of said particle movement relative to said magnetic field.
Claim 12
Independent Claim
196 words
A method for performing a prothrombin time assay, comprising: (i) subjecting to an oscillating magnetic field a reaction slide bearing (1) a sample well for receiving a liquid sample and (2) a reaction chamber containing a dry reagent matrix in which is embedded a plurality of magnetic particles distributed homogeneously therethrough, wherein said reagent is one member selected from the group consisting of prothrombin time assay reagents; said sample well and reaction chamber being in fluid connection through a transport zone of geometry such that a volume of liquid analyte sample placed in said sample well and corresponding to the volume of said reaction chamber is transported from said sample well to said reaction chamber simultaneously; (ii) adding a whole blood or plasma sample to said sample well whereby said sample is introduced simultaneously to said reaction chamber, said reagent is solubilized and said particles are freed to move in an oscillating pattern induced by said oscillating magnetic field; and (iii) optically monitoring said reaction chamber to measure a start time and a stop time for said prothrombin time assay, corresponding to a change in the degree of said particle movement relative to said magnetic field.
Claim 13
Dependent Claim
11 words
The method of claim 10, wherein said magnetic particles are magnetite.
Claim 14
Dependent Claim
16 words
The method of claim 10, wherein said reaction chamber is subjected to a permanent magnetic field.
Claim 15
Dependent Claim
24 words
The method of claim 10, wherein said reaction chamber is optically monitored by impinging light thereon and detecting light reflected from said reaction chamber.
Claim 16
Dependent Claim
13 words
The method of claim 10, wherein said sample is a whole blood sample.
Claim 17
Dependent Claim
12 words
The method of claim 10, wherein said sample is a plasma sample.
Claim 18
Dependent Claim
13 words
The method of claim 10, wherein said reagent comprises thromboplastin and calcium chloride.
References Cited (Backward Citations)
US27866A
Cited
US2616796A
Cited
US3233975A
Cited
US3434859A
Cited
US3395210A
Cited
US3690836A
Cited
US3450501A
Cited
US3520659A
Cited
US3635678A
Cited
USRE27866E
Cited
US3650698A
Cited
US3836333A
Cited
US3695842A
Cited
US3691017A
Cited
US3861197A
Cited
US3880714A
Cited
US4062652A
Cited
US3918908A
Cited
US4088448A
Cited
US4252536A
Cited
US4344438A
Cited
US4233029A
Cited
US4310399A
Cited
US4302313A
Cited
US4321057A
Cited
US4323536A
Cited
US4413407A
Cited
US4477575A
Cited
US4477575B1
Cited
US4426451A
Cited
US4340669A
Cited
US4391905A
Cited
US4391906A
Cited
US4473457A
Cited
US4582684A
Cited
US4558014A
Cited
US4654127A
Cited
WO1986000141A1
Cited
US4596695A
Cited
GB2168808A
Cited
US4678757A
Cited
DE3523439A1
Cited
US4756884A
Cited
US4682895A
Cited
US4712460A
Cited
US4731330A
Cited
US4753776A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-07-17 | 1993-01-16 | 1993-07-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-07-17 | 1997-01-16 | 1997-07-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-07-17 | 2001-01-16 | 2001-07-18 | $7700.00 | Window Closed / Lapsed |